Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2010
06/09/2010EP2193122A1 Imidazole derivatives
06/09/2010EP2193119A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
06/09/2010EP1335907B1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
06/09/2010CN1926108B Non-nucleotide reverse transcriptase inhibitors
06/09/2010CN1784391B Quinazolines useful as modulators of ion channels
06/09/2010CN1694874B Benzodiazepine derivatives and pharmaceutical compositions containing them
06/09/2010CN101730689A 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
06/09/2010CN101730688A 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides
06/09/2010CN101730686A Piperazine compounds with herbicidal action
06/09/2010CN101730680A 4' substituted compounds having 5-ht6 receptor affinity
06/09/2010CN101723901A Method for preparing 2-propylbenzimidazole
06/09/2010CN101723900A Cinnamide compound
06/09/2010CN101723893A 2,3-disubstituted-2,3-dihydro quinoline ketone chiral compound as well as preparation method and application thereof
06/09/2010CN101723768A Method for carrying out hydroxyethylation on phenolic acid compounds and products thereof
06/09/2010CN101119989B Chroman derivatives and uses thereof in treating CNS disease
06/08/2010US7732600 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
06/08/2010US7732464 non-selective and selective serotonin receptor antagonists, usedfor for treating gastrointestinal disorders such as hypermotility, irritable bowel syndrome (IBS), constipation or diarrhea predominant IBS, pain and non-pain predominant IBS and bowel hypersensitivity
06/08/2010US7732463 such as 4-[2-(4-Chloro-phenylsulfanyl)-5-trifluoromethyl-phenyl]-piperidine, used as antidepressants and anxiolytic agents; treatment of panic and obsessive compulsive disorders
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732448 pesticides such as 4-(2-butynyloxy)-6-chloro-5-fluoropyrimidine, having an excellent ability to control pests
06/08/2010US7732444 4-{2-[4-(3-{[(3-Amino-propyl)-ethyl-amino]-methyl}-phenyl)-pyrimidin-2-ylamino]-ethyl}-phenol, used as protein kinase C inhibitors
06/08/2010US7732413 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7731985 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints
06/08/2010CA2479831C Benzofuran derivative
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/08/2010CA2416442C Substituted 5-alkynyl pyrimidines having neurotrophic activity
06/03/2010WO2010062221A1 Substituted 2-(5-hydroxy-2-methyl-1n-indole-3-il) acetic acids and ethers thereof and the use of same to treat viral diseases
06/03/2010WO2010061971A1 Pyridine-3-carboxyamide derivative
06/03/2010WO2010061903A1 Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
06/03/2010WO2010061824A1 Aromatic amine derivative, and organic electroluminescent element
06/03/2010WO2010061400A1 A novel process for the preparation of lapatinib and its pharmaceutically acceptable salts
06/03/2010WO2010061282A1 Derivatives of [(3-hydroxy-4 pyron-2-yl)methyl]-amine and use thereof as anti-neoplastic drugs
06/03/2010WO2010060703A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists
06/03/2010WO2009061652A8 Compounds which modulate the cb2 receptor
06/03/2010US20100137606 Novel compound having beta-secretase inhibitory activity
06/03/2010US20100137603 Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
06/03/2010US20100137582 N-pyridylpiperidine compound, method for producing the same, and pest control agent
06/03/2010US20100137390 1,3-Dihydroimidazole-2-Thione Derivatives as Inhibitors of Dopamine-Beta-Hydroxylase
06/03/2010US20100137360 Trpv1 antagonists
06/03/2010US20100137359 Caspase inhibitors and uses thereof
06/03/2010US20100137334 Piperidine and Piperazine Derivatives
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137322 Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
06/03/2010US20100137317 1,2-Disubstituted Heterocyclic Compounds
06/03/2010US20100137312 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
06/03/2010US20100137308 Quinoxaline Compounds and Use Thereof
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137273 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/03/2010CA2743018A1 Substituted pyrazole compounds
06/03/2010CA2742463A1 3-(benzylamin0)-pyrr0lidine derivatives and their use as nk-3 receptor antagonists
06/03/2010CA2740977A1 A novel process for the preparation of lapatinib and its pharmaceutically acceptable salts
06/02/2010EP2192116A1 Indazole acrylic acid amide compound
06/02/2010EP2192113A1 Novel crystal form XI of atorvastatin hemi-calcium and processes for its preparation
06/02/2010EP2192112A1 Process for preparing atorvastatin hemi-calcium Form I
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2191006A1 Methods for assaying alpha-l-iduronidase enzymatic activity
06/02/2010EP2190838A1 Cannabinoid receptor ligands
06/02/2010EP2190836A1 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
06/02/2010EP2190822A2 5-membered heterocyclic compounds as proton pump inhibitors
06/02/2010EP2001478B1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
06/02/2010EP1890672B1 Use of chromone derivatives
06/02/2010EP1745040B9 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
06/02/2010EP1658263B1 Novel aminobenzophenone compounds
06/02/2010EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance
06/02/2010CN1832942B Novel process for the preparation of 2h-chromenes
06/02/2010CN1809559B Pyrazole derivatives as phosphodiesterase 4 inhibitors
06/02/2010CN101720323A Compounds with anti-cancer activity
06/02/2010CN101720318A Quinazolin-oxime derivatives as hsp90 inhibitors
06/02/2010CN101717361A Diazo naphthoquinone sulphonate sensitizer containing protecting groups capable of acid decomposition, and synthesis method thereof
06/01/2010US7728150 N-[3-(1-Ethyl-5-fluoro-indan-1-yl)-1H-indol-7-yl]-methanesulfonamide; for treating congestive heart disease, hypertension, and atherosclerosis
06/01/2010US7728010 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727713 Templated molecules and methods for using such molecules
06/01/2010US7727511 Agents for imaging soluble a-beta
06/01/2010CA2448737C Viral polymerase inhibitors
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2367671C Process for the preparation of the polymorph a of doxazosin mesylate
06/01/2010CA2352524C Aromatic heterocyclic compounds as antiinflammatory agents
05/2010
05/27/2010WO2010059922A1 Pyrrolidine carboxamide compounds
05/27/2010WO2010059393A1 Serotonin receptor modulators
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058060A1 Aryl piperazine and their use as alpha2c antagonists
05/27/2010WO2010058032A2 New compounds
05/27/2010WO2010058030A1 New compounds
05/27/2010WO2010057899A1 Cycloalkyl amino carbonyl derivatives as bradykinin-b1 receptor antagonists
05/27/2010WO2010057833A1 Compounds for treatment of duchenne muscular dystrophy
05/27/2010WO2010038081A3 4-amino-5- (hetero) aryl-2-phenylamino-pyrimidine or pyridine and their use as dna gyrase and/or topoisomerase iv inhibitors
05/27/2010WO2010036638A3 Compounds for the treatment of inflammatory disorders
05/27/2010WO2010013222A8 Pyrrole carboxylic acid derivatives as antibacterial agents
05/27/2010WO2010000372A3 New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
05/27/2010WO2009153178A3 Aryl ketone as mri
05/27/2010WO2009140624A3 Glucokinase activators
05/27/2010WO2009096668A3 Improved process for preparing mycophenolate mofetil
05/27/2010US20100130749 Methods
05/27/2010US20100130556 Ep2 receptor agonists
05/27/2010US20100130513 Benzimidazoles and analogs thereof as antivirals
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 694